Tarsus Pharmaceuticals, Inc. TARS
NASDAQ · United States · Health Technology
$77.07-1.55 (-1.97%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.43 | -0.19 | -124.2% | $173.91M | +2.5% | +5.7%$61.29→$64.79 |
| Q1 2026 | 2026-05-06 | -0.16 | -0.46 | +65.2% | — | — | -1.7%$65.04→$63.96 |
| Q4 2025 | 2026-02-23 | -0.20 | 0.01 | -2,100.0% | — | — | +12.6%$66.61→$75.01 |
| Q3 2025 | 2025-11-04 | -0.30 | -0.35 | +14.3% | — | — | -2.3%$69.79→$68.20 |
| Q4 2024 | 2025-02-25 | -0.60 | -0.78 | +23.1% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.61 | -1.00 | +39.0% | — | — | — |
| Q4 2023 | 2024-02-27 | -1.31 | -1.49 | +12.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.